Open AccessComplete pathological response in locally advanced non-small-cell lung cancer patient: A case report
Author(s) -
Elisabetta Parisi,
D. Arpa,
Giuglia Ghigi,
S. Micheletti,
Elisa Neri,
Luca Tontini,
M. Pieri,
Antonino Romeo
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i20.5540
Subject(s) - medicine , pathological , lung cancer , complete response , pathology , lung , radiology , oncology , chemotherapy
Chemotherapy and radiotherapy followed by durvalumab is currently the standard treatment for locally advanced node-positive non-small-cell lung cancer (NSCLC). We describe the case of a patient with locally advanced node-positive NSCLC (LA-NSCLC) treated in a phase II prospective protocol with chemotherapy, accelerated hypofractionated radiotherapy (AHRT) and surgery in the pre-immunotherapy era.